当前位置: X-MOL 学术Drug. Discov. Today › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Artificial intelligence and the future of life sciences
Drug Discovery Today ( IF 6.5 ) Pub Date : 2021-07-08 , DOI: 10.1016/j.drudis.2021.07.002
Michel L Leite 1 , Lorena S de Loiola Costa 2 , Victor A Cunha 2 , Victor Kreniski 3 , Mario de Oliveira Braga Filho 3 , Nicolau B da Cunha 2 , Fabricio F Costa 4
Affiliation  

Over the past few decades, the number of health and ‘omics-related data’ generated and stored has grown exponentially. Patient information can be collected in real time and explored using various artificial intelligence (AI) tools in clinical trials; mobile devices can also be used to improve aspects of both the diagnosis and treatment of diseases. In addition, AI can be used in the development of new drugs or for drug repurposing, in faster diagnosis and more efficient treatment for various diseases, as well as to identify data-driven hypotheses for scientists. In this review, we discuss how AI is starting to revolutionize the life sciences sector.



中文翻译:

人工智能与生命科学的未来

在过去的几十年中,生成和存储的健康和“组学相关数据”的数量呈指数增长。可以在临床试验中使用各种人工智能 (AI) 工具实时收集和探索患者信息;移动设备也可用于改善疾病的诊断和治疗。此外,人工智能可用于新药开发或药物再利用,更快地诊断和更有效地治疗各种疾病,以及为科学家识别数据驱动的假设。在这篇评论中,我们讨论了人工智能如何开始彻底改变生命科学领域。

更新日期:2021-07-08
down
wechat
bug